Understanding AUTM's Guidelines
Our industry has undergone increased scrutiny with respect to roles, responsibilities and outcomes associated with the commercialization process. Academic inventors and institutions both have a vested interest, as does the public, as commercialization leads to new products, medicines and other advancements that benefit us all.
The AUTM Guidelines for Balancing Stakeholders’ Interests seeks to define and balance these varied, and sometimes only partially aligned, aims. Read more